These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 8722550)

  • 1. Zidovudine absorption and small intestinal function in HIV seropositive patients.
    Macnab KA; Gill MJ; Sutherland LR; Murphy A; Brant R
    J Antimicrob Chemother; 1996 Apr; 37(4):825-9. PubMed ID: 8722550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Erratic zidovudine bioavailability in HIV seropositive patients.
    Macnab KA; Gill MJ; Sutherland LR; De Boer Visser N; Church D
    J Antimicrob Chemother; 1993 Mar; 31(3):421-8. PubMed ID: 8098029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Absorption of zidovudine in patients with diarrhoea.
    Zorza G; Beaugerie L; Taburet AM; Le Quintrec Y; Singlas E
    Eur J Clin Pharmacol; 1993; 44(5):501-3. PubMed ID: 8359192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral and intravenous zidovudine pharmacokinetics: the effect of granulocyte-macrophage colony stimulating factor.
    Aweeka FT; Mak M; al-Uzri A; Peter K; Dett C; Franco J; Affrime M; Guerciolini R; Cutler DL; Kahn J
    J Clin Pharmacol; 1995 Sep; 35(9):856-64. PubMed ID: 8786245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased oral ganciclovir bioavailability in HIV-infected patients with chronic diarrhoea and wasting syndrome--a population pharmacokinetic study.
    Mouly S; Aymard G; Tillement JP; Caulin C; Bergmann JF; Urien S
    Br J Clin Pharmacol; 2001 Jun; 51(6):557-65. PubMed ID: 11422015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impaired absorption of zidovudine in patients with AIDS-related small intestinal disease.
    Kapembwa MS; Fleming SC; Orr M; Wells C; Bland M; Back D; Griffin GE
    AIDS; 1996 Nov; 10(13):1509-14. PubMed ID: 8931785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic individualisation of zidovudine therapy. Current state of pharmacokinetic-pharmacodynamic relationships.
    Hoetelmans RM; Burger DM; Meenhorst PL; Beijnen JH
    Clin Pharmacokinet; 1996 Apr; 30(4):314-27. PubMed ID: 8983861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of simultaneously administered zidovudine and didanosine in HIV-seropositive male patients.
    Sahai J; Gallicano K; Garber G; Pakuts A; Cameron W
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Sep; 10(1):54-60. PubMed ID: 7648285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative assessment of small intestinal and colonic permeability in HIV-infected homosexual men.
    Obinna FC; Cook G; Beale T; Dave S; Cunningham D; Fleming SC; Claydon E; Harris JW; Kapembwa MS
    AIDS; 1995 Sep; 9(9):1009-16. PubMed ID: 8527072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered small-intestinal permeability associated with diarrhoea in human-immunodeficiency-virus-infected Caucasian and African subjects.
    Kapembwa MS; Fleming SC; Sewankambo N; Serwadda D; Lucas S; Moody A; Griffin GE
    Clin Sci (Lond); 1991 Sep; 81(3):327-34. PubMed ID: 1655333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative pharmacokinetics of zidovudine (AZT) and its metabolite (G.AZT) in healthy subjects and HIV seropositive patients.
    Singlas E; Pioger JC; Taburet AM; Colaneri S; Fillastre JP
    Eur J Clin Pharmacol; 1989; 36(6):639-40. PubMed ID: 2776824
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmacokinetics of oral zidovudine (azidothymidine) in patients with AIDS when administered with and without a high-fat meal.
    Unadkat JD; Collier AC; Crosby SS; Cummings D; Opheim KE; Corey L
    AIDS; 1990 Mar; 4(3):229-32. PubMed ID: 2350441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prolonged, but not diminished, zidovudine absorption induced by a high-fat breakfast.
    Shelton MJ; Portmore A; Blum MR; Sadler BM; Reichman RC; Morse GD
    Pharmacotherapy; 1994; 14(6):671-7. PubMed ID: 7885970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atovaquone inhibits the glucuronidation and increases the plasma concentrations of zidovudine.
    Lee BL; Täuber MG; Sadler B; Goldstein D; Chambers HF
    Clin Pharmacol Ther; 1996 Jan; 59(1):14-21. PubMed ID: 8549029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of valganciclovir and ganciclovir following multiple oral dosages of valganciclovir in HIV- and CMV-seropositive volunteers.
    Brown F; Banken L; Saywell K; Arum I
    Clin Pharmacokinet; 1999 Aug; 37(2):167-76. PubMed ID: 10496303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single dose, dose-escalating trial with fozivudine tidoxil (BM 21.1290).
    Bogner JR; Boerner D; Mühlhöfer A; Thoma-Greber E; Herrmann DB; Hoegl L; Roecken M; Jost V; Goebel FD
    Antivir Ther; 1997 Dec; 2(4):249-56. PubMed ID: 11327444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of sex and contraceptive therapy on the plasma and intracellular pharmacokinetics of zidovudine.
    Aweeka FT; Rosenkranz SL; Segal Y; Coombs RW; Bardeguez A; Thevanayagam L; Lizak P; Aberg J; Watts DH;
    AIDS; 2006 Sep; 20(14):1833-41. PubMed ID: 16954724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma viremia as a sensitive indicator of the antiretroviral activity of L-697,661.
    Davey RT; Dewar RL; Reed GF; Vasudevachari MB; Polis MA; Kovacs JA; Falloon J; Walker RE; Masur H; Haneiwich SE
    Proc Natl Acad Sci U S A; 1993 Jun; 90(12):5608-12. PubMed ID: 8516307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of zidovudine after the initial single dose and during chronic-dose therapy in HIV-infected patients.
    Gallicano K; Sahai J; Ormsby E; Cameron DW; Pakuts A; McGilveray I
    Br J Clin Pharmacol; 1993 Aug; 36(2):128-31. PubMed ID: 8398581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Strategies for control of zidovudine concentrations in serum.
    Noormohamed SE; Henry WK; Rhame FS; Balfour HH; Fletcher CV
    Antimicrob Agents Chemother; 1995 Dec; 39(12):2792-7. PubMed ID: 8593022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.